Last updated on August 2018

Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States


Find a site near you

Start Over

Weill Cornell Medicine

New York, NY United States
  Connect »

Mt. Sinai Hospital

Chicago, IL United States
  Connect »

Stony Brook Cancer Center

Stony Brook, NY United States
  Connect »

Alexian Brothers Cancer Institute

Elk Grove Village, IL United States
  Connect »

Oncology Hematology Care

Cincinnati, OH United States
  Connect »

Cancer Center of Kansas

Wichita, KS United States
  Connect »

Huntsman Cancer Hospital

Salt Lake City, UT United States
  Connect »

Willis Knighton Cancer Center

Shreveport, LA United States
  Connect »

John Theurer Cancer Center

Hackensack, NJ United States
  Connect »

Healthcare Research Network

Tinley Park, IL United States
  Connect »

ARH Hazard

Hazard, KY United States
  Connect »

Saint Agnes Hospital

Baltimore, MD United States
  Connect »

Frontier Cancer Center

Billings, MT United States
  Connect »

Leo W. Jenkins Cancer Center

Greenville, NC United States
  Connect »